Dexamethasone eye drops containing γ-cyclodextrin-based nanogels

International Journal of Pharmaceutics

Volumn 441, Issue 1-2, 2013, Pages 507-515

  Moya Ortega, Maria D ^a   Alves, Tiago F G ^b   Alvarez Lorenzo, Carmen ^c   Concheiro, Angel ^c   Stefánsson, Einar ^d   Thorsteinsdóttir, Margrét ^a   Loftsson, Thorsteinn ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Cyclodextrin; Dexamethasone; Eye drop; Nanogels; Ocular drug delivery

Indexed keywords

2 HYDROXYPROPYL GAMMA CYCLODEXTRIN; DEXAMETHASONE; EYE DROPS; GAMMA CYCLODEXTRIN; SOLVENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS HUMOR; AQUEOUS SOLUTION; ARTICLE; BIOCOMPATIBILITY; CHEMICAL COMPOSITION; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSS LINKING; DRUG SOLUBILITY; DRUG TOLERABILITY; EMULSION; EVAPORATION; GEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VIVO STUDY; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUSPENSION; VISCOSITY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AQUEOUS HUMOR; BETA-CYCLODEXTRINS; DELAYED-ACTION PREPARATIONS; DEXAMETHASONE; DRUG DELIVERY SYSTEMS; EMULSIONS; GAMMA-CYCLODEXTRINS; GELS; OPHTHALMIC SOLUTIONS; RABBITS; SOLUBILITY; TIME FACTORS;

EID: 84872812734     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.11.002     Document Type: Article

References (47)

1. M.B. Abelson, M.J. Chapin, P. Gomes, G. Minno, and J. Nice Ophthalmic Formulations of Cetirizine and Fluticasone for Treatment of Allergic Conjunctivitis, Allergic Rhinoconjunctivitis and Rhinitis 2011 Aciex Therapeutics, Inc. USA 91pp., Cont.-in-part of U.S. Ser. No. 724,128
2. R.A. Bejjani, F. Behar-Cohen, D. Benezra, R. Gurny, and F. Delie Polymeric nanoparticles for drug delivery to the posterior segment of the eye CHIMIA 59 2005 344 347
3. J.A. Cardillo, F. Paganelli, L.A.S. Melo Jr., A.A. Silva Jr., A.C. Pizzolitto, and A.G. Oliveira Subconjunctival delivery of antibiotics in a controlled-release system: a novel anti-infective prophylaxis approach for cataract surgery Arch. Ophthalmol. 128 2010 81 87
4. Y.L. Colson, and M.W. Grinstaff Biologically responsive polymeric nanoparticles for drug delivery Adv. Mater. 24 2012 3878 3886
5. Y.E. Choonara, V. Pillay, T.R. Carmichael, L.C.R. Meyer, T.L.C. Du, S. Naylor, and C. Wanblad In vivo evaluation of a biodegradable donut-shaped minitablet for prolonged posterior segment drug delivery in the rabbit eye model J. Pharm. Sci. 100 2011 1819 1832
6. Y.E. Choonara, V. Pillay, M.P. Danckwerts, T.R. Carmichael, and T.L.C. du A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases J. Pharm. Sci. 99 2010 2219 2239
7. Y. Diebold, M. Jarrin, V. Saez, E.L.S. Carvalho, M. Orea, M. Calonge, B. Seijo, and M.J. Alonso Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP) Biomaterials 28 2007 1553 1564
8. S. Daoud-Mahammed, S.A. Agnihotri, K. Bouchemal, S. Kloters, P. Couvreur, and R. Gref Efficient loading and controlled release of benzophenone-3 entrapped into self-assembling nanogels Curr. Nanosci. 6 2010 654 665
9. A. Einstein Über die von der molekularkinetischen Theorie der Wärme geforderte Bewegung von in ruhenden Flüssigkeiten suspendierten Teilchen Ann. Phys. 322 1905 549 560
10. G. González-Gaitano, P. Rodriguez, J.R. Isasi, M. Fuentes, G. Tardajos, and M. Sanchez The aggregation of cyclodextrins as studied by photon correlation spectroscopy J. Incl. Phenom. Macro. Chem. 44 2002 101 105
11. L.G. Guerrero-Ramirez, S.M. Nuno-Donlucas, L.C. Cesteros, and I. Katime Smart copolymeric nanohydrogels: synthesis, characterization and properties Mater. Chem. Phys. 112 2008 1088 1092
12. S. Gupta, R. Gabrani, J. Ali, and S. Dang Exploring novel approaches to vaginal drug delivery Recent Pat. Drug Deliv. Formul. 5 2011 82 94
13. S.L. Harikumar, and A. Sonia Nanotechnological approaches in ophthalmic delivery systems Int. J. Drug Dev. Res. 3 2011 9 19
14. T. Higuchi, and K.A. Connors Phase-solubility techniques C.N. Reilley, Advances in Analytical Chemistry and Instrumentation vol. 4 1965 Interscience New York 117 212
15. K. Ikeda, T. Okada, S.-I. Sawada, K. Akiyoshi, and K. Matsuzaki Inhibition of the formation of amyloid β-protein fibrils using biocompatible nanogels as artificial chaperones FEBS Lett. 580 2006 6587 6595
16. P. Jansook, and T. Loftsson γCD/HPγCD: synergistic solubilization Int. J. Pharm. 363 2008 217 219
17. P. Jansook, and T. Loftsson CDs as solubilizers: effects of excipients and competing drugs Int. J. Pharm. 379 2009 32 40
18. P. Jansook, G.C. Ritthidej, H. Ueda, E. Stefánsson, and T. Loftsson yCD/HPyCD mixtures as solubilizer: solid-state characterization and sample dexamethasone eye drop suspension J. Pharm. Pharm. Sci. 13 2010 336 350
19. P. Jansook, E. Stefánsson, M. Thorsteinsdóttir, B.B. Sigurdsson, S.S. Kristjánsdóttir, J.F. Bas, H.H. Sigurdsson, and T. Loftsson Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: Formulation of dorzolamide eye drop microparticle suspension Eur. J. Pharm. Biopharm. 76 2010 208 214
20. R. Jayakumar, A. Nair, N.S. Rejinold, S. Maya, and S.V. Nair Doxorubicin-loaded pH-responsive chitin nanogels for drug delivery to cancer cells Carbohydr. Polym. 87 2012 2352 2356
21. M.J. Kettel, F. Dierkes, K. Schaefer, M. Moeller, and A. Pich Aqueous nanogels modified with cyclodextrin Polymer 52 2011 1917 1924
22. T. Loftsson, and D. Hreinsdóttir Determination of aqueous solubility by heating and equilibration: a technical note AAPS PharmSciTech 7 2006 E29 E32
23. T. Loftsson, D. Hreinsdottir, and E. Stefansson Cyclodextrin microparticles for drug delivery to the posterior segment of the eye: aqueous dexamethasone eye drops J. Pharm. Pharmacol. 59 2007 629 635
24. M. Messner, S.V. Kurkov, M.E. Brewster, P. Jansook, and T. Loftsson Self-assembly of cyclodextrin complexes: aggregation of hydrocortisone/ cyclodextrin complexes Int. J. Pharm. 407 2011 174 183
25. M. Messner, S.V. Kurkov, M.M. Palazón, B.Á. Fernández, M.E. Brewster, and T. Loftsson Self-assembly of cyclodextrin complexes: effect of temperature, agitation and media composition on aggregation Int. J. Pharm. 419 2011 322 328
26. M.D. Moya-Ortega, C. Alvarez-Lorenzo, H.H. Sigurdsson, A. Concheiro, and T. Loftsson γ-Cyclodextrin hydrogels and semi-interpenetrating networks for sustained delivery of dexamethasone Carbohydr. Polym. 80 2010 900 907
27. M.D. Moya-Ortega, C. Alvarez-Lorenzo, A. Concheiro, and T. Loftsson Cyclodextrin-based nanogels for pharmaceutical and biomedical applications Int. J. Pharm. 428 2012 152 163
28. M.D. Moya-Ortega, C. Alvarez-Lorenzo, H.H. Sigurdsson, A. Concheiro, and T. Loftsson Cross-linked hydroxypropyl-β-cyclodextrin and γ-cyclodextrin nanogels for drug delivery: physicochemical and loading/release properties Carbohydr. Polym. 87 2012 2344 2351
29. M. Mudgil, N. Gupta, M. Nagpal, and P. Pawar Nanotechnology: a new approach for ocular drug delivery system Int. J. Pharm. Pharm. Sci. 4 2012 105 112
30. B.K. Nanjwade, R.V. Deshmukh, K.R. Gaikwad, K.A. Parikh, and F.V. Manvi Formulation and evaluation of micro hydrogel of Moxifloxacin hydrochloride Eur. J. Drug Metab. Pharmacokinet. 37 2012 117 123
31. NICEATM-ICCVAM. In vivo test methods for detecting ocular corrosives and severe irritants. http://iccvam.niehs.nih.gov/methods/ocutox/ivocutox.htm (accessed on October 2012).
32. J. Oh, R. Drumright, D. Siegwart, and K. Matyjaszewski The development of microgels/nanogels for drug delivery applications Prog. Polym. Sci. 33 2008 448 477
33. F. Paganelli, J.A. Cardillo, A.R.J. Dare, L.A.S. Melo Jr., D.R. Lucena, A.A. Silva Jr., A.G. Oliveira, A.C. Pizzolitto, D. Lavinsky, M. Skaf, A.A. Souza-Filho, A.L. Hoefling-Lima, Q.D. Nguyen, B.D. Kuppermann, R. Herrero-Vanrell, and R. Belfort Jr. Controlled transscleral drug delivery formulations to the eye: establishing new concepts and paradigms in ocular anti-inflammatory therapeutics and antibacterial prophylaxis Expert Opin. Drug Deliv. 7 2010 955 965
34. R. Parhi, and P. Suresh Preparation and characterization of solid lipid nanoparticles - a review Curr. Drug Discov. Technol. 9 2012 2 16
35. L. Pitkanen, V.-P. Ranta, H. Moilanen, and A. Urtti Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity Invest. Ophthalmol. Vis. Sci. 46 2005 641 646
36. Y.-S. Rhee, and H.M. Mansour Nanopharmaceuticals I: nanocarrier systems in drug delivery Int. J. Nanotechnol. 8 2011 84 114
37. S. Sawada, Y. Sasaki, Y. Nomura, and K. Akiyoshi Cyclodextrin-responsive nanogel as an artificial chaperone for horseradish peroxidase Colloid Polym. Sci. 289 2011 685 691
38. H.H. Sigurdsson, E. Stefánsson, E. Gudmundsdóttir, T. Eysteinsson, M. Thorsteinsdóttir, and T. Loftsson Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration J. Control. Release 102 2005 255 262
39. D. Small, J. Hevy, and D. Tang-Liu Comparison of tear sampling techniques for pharmacokinetic analysis: ofloxacin concentrations in rabbit tears after sampling with schirmer tear strips, capillary tubes, or surgical sponges J. Ocul. Pharmacol. Ther. 16 2000 439 446
40. M. von Smoluchowski Zur kinetischen Theorie der Brownschen Molekularbewegung und der Suspensionen Ann. Phys. 326 1906 756 780
41. N.A. Samah, N. Williams, and C.M. Heard Nanogel particulates located within diffusion cell receptor phases following topical application demonstrates uptake into and migration across skin Int. J. Pharm. 401 2010 72 78
42. E.B. Souto, S. Doktorovova, and P. Boonme Lipid-based colloidal systems (nanoparticles, microemulsions) for drug delivery to the skin: materials and end-product formulations J. Drug Deliv. Sci. Technol. 21 2011 43 54
43. S. Tauber, G. Cupp, R. Garber, J. Bartell, F. Vohra, and D. Stroman Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis Adv. Ther. 28 2011 566 574
44. A. Thakur, R.S. Kadam, and U.B. Kompella Influence of drug solubility and lipophilicity on transscleral retinal delivery of six corticosteroids Drug Metab. Dispos. 39 2011 771 781
45. A. Tiwari, and R.K. Shukla Novel ocular drug delivery systems: an overview J. Chem. Pharm. Res. 2 2010 348 355
46. E.V. Ukhatskaya, S.V. Kurkov, S.E. Matthews, A. El Fagui, C. Amiel, F. Dalmas, and T. Loftsson Evaluation of a cationic calixarene: solubilization and self-aggregation ability Int. J. Pharm. 402 2010 10 19
47. S. Wadhwa, R. Paliwal, S.R. Paliwal, and S.P. Vyas Nanocarriers in ocular drug delivery: an update review Curr. Pharm. Des. 15 2009 2724 2750